Karyopharm Therapeutics Inc. KPTI

Set alert

Price alert · KPTI

All alert types
0.11 USD -0.55 -83.08%

At close · Nov 2

0.12 +0.01 +7.05%

After hours · Nov 2, 7:59 PM ET

Bid
0.11 × 1
Ask
0.11 × 1
0.0946 Day range 0.16
0.112 52-week range 10.67
YTD
-98.48%
1 year
-98.07%
Open
0.153
Prev close
0.662
Mkt cap
2.54M
Vol
46.92M
Avg vol
2.56M
EPS
-2.40
P/E
0.00
Div yield
0.00%
More statistics
Low
0.0946
High
0.16
Forward P/E
-0.87
Beta
0.15
Short ratio
19.48
Inst. own
48.24%
Dividend
0.00
Ex-div date
50-d avg
0.81746
200-d avg
0.959155
1y target
4.50

5D chart

Chart tools
Interval

Signals (132)
NameTimeAgo
SMA: BullishNov 2, 3:45 PM11 hours ago
SMA: BullishNov 2, 3:45 PM11 hours ago
SMA: BearishNov 2, 3:35 PM11 hours ago
SMA: BearishNov 2, 3:30 PM11 hours ago
SMA: BullishNov 2, 3:25 PM11 hours ago
SMA: BullishNov 2, 3:00 PM11 hours ago
SMA: BearishNov 2, 2:00 PM12 hours ago
SMA: BullishNov 2, 1:55 PM12 hours ago
SMA: BearishNov 2, 1:50 PM13 hours ago
SMA: BearishNov 2, 1:50 PM13 hours ago
SMA: BullishNov 2, 1:30 PM13 hours ago
SMA: BullishNov 2, 1:30 PM13 hours ago
SMA: BearishNov 2, 1:25 PM13 hours ago
SMA: BullishNov 2, 1:15 PM13 hours ago
SMA: BearishNov 2, 1:10 PM13 hours ago
SMA: BullishNov 2, 1:00 PM13 hours ago
SMA: BearishNov 2, 12:55 PM13 hours ago
RSI: OversoldNov 2, 12:55 PM13 hours ago
SMA: BearishNov 2, 12:45 PM14 hours ago
SMA: BullishNov 2, 12:40 PM14 hours ago

Newest 20 of 132.

Revenue & Expenses

Revenue → Gross Profit: $140.12MGross Profit → Expenses: $140.12MRevenue → Cost of Revenue: $5.95MExpenses → Selling, General & Admin: $105.21MExpenses → Research & Development: $125.62MExpenses → Interest Expense: $45.85MExpenses → Other Expenses: $59.44MExpenses → Income Tax: $43.00KNet Loss → Expenses: $196.04MGross Profit$140.12MNet Loss$196.04MCost of Revenue$5.95MExpenses$336.16MSelling, General & Admin$105.21MResearch & Development$125.62MInterest Expense$45.85MOther Expenses$59.44MIncome Tax$43.00KRevenue$146.07M

Latest period ending Dec 31, 2025 · select a line to chart its full history

KPTI annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
146.07M145.24M146.03M157.07M209.82M
140.12M139.23M141.09M151.86M206.42M
-90.71M-119.44M-129.54M-142.20M-98.27M
-196.04M-76.42M-143.10M-165.29M-124.09M
-17.93-14.00-18.79-30.30-24.70
KPTI annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
60.89M62.81M53.19M136.88M197.44M
108.42M164.42M240.44M358.17M305.31M
401.34M350.44M376.64M374.83M384.98M
233.61M194.52M177.02M179.07M180.58M
-292.93M-186.02M-136.21M-16.66M-79.67M
KPTI annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-75.37M-127.49M-92.72M-149.55M-107.12M
43.38M95.47M7.94M-104.26M141.84M
30.05M41.65M1.12M193.74M73.65M
-1.92M9.62M-83.69M-60.56M108.32M